BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 26886596)

  • 1. Fbxw7 Tumor Suppressor: A Vital Regulator Contributes to Human Tumorigenesis.
    Cao J; Ge MH; Ling ZQ
    Medicine (Baltimore); 2016 Feb; 95(7):e2496. PubMed ID: 26886596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor suppression by the Fbw7 ubiquitin ligase: mechanisms and opportunities.
    Davis RJ; Welcker M; Clurman BE
    Cancer Cell; 2014 Oct; 26(4):455-64. PubMed ID: 25314076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant regulation of FBW7 in cancer.
    Wang L; Ye X; Liu Y; Wei W; Wang Z
    Oncotarget; 2014 Apr; 5(8):2000-15. PubMed ID: 24899581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FBXW7/hCDC4 is a general tumor suppressor in human cancer.
    Akhoondi S; Sun D; von der Lehr N; Apostolidou S; Klotz K; Maljukova A; Cepeda D; Fiegl H; Dafou D; Marth C; Mueller-Holzner E; Corcoran M; Dagnell M; Nejad SZ; Nayer BN; Zali MR; Hansson J; Egyhazi S; Petersson F; Sangfelt P; Nordgren H; Grander D; Reed SI; Widschwendter M; Sangfelt O; Spruck C
    Cancer Res; 2007 Oct; 67(19):9006-12. PubMed ID: 17909001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human adenovirus-p53 injection induced apoptosis in hepatocellular carcinoma cell lines mediated by p53-Fbxw7 pathway, which controls c-Myc and cyclin E.
    Tu K; Zheng X; Zhou Z; Li C; Zhang J; Gao J; Yao Y; Liu Q
    PLoS One; 2013; 8(7):e68574. PubMed ID: 23840897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Fbxw7/hCdc4 tumor suppressor in human cancer.
    Tan Y; Sangfelt O; Spruck C
    Cancer Lett; 2008 Nov; 271(1):1-12. PubMed ID: 18541364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential regulation of FBXW7 isoforms by various stress stimuli.
    Sionov RV; Netzer E; Shaulian E
    Cell Cycle; 2013 Nov; 12(22):3547-54. PubMed ID: 24091628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conditional inactivation of Fbxw7 impairs cell-cycle exit during T cell differentiation and results in lymphomatogenesis.
    Onoyama I; Tsunematsu R; Matsumoto A; Kimura T; de Alborán IM; Nakayama K; Nakayama KI
    J Exp Med; 2007 Nov; 204(12):2875-88. PubMed ID: 17984302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. F-box and WD repeat domain-containing-7 (Fbxw7) protein targets endoplasmic reticulum-anchored osteogenic and chondrogenic transcriptional factors for degradation.
    Yumimoto K; Matsumoto M; Onoyama I; Imaizumi K; Nakayama KI
    J Biol Chem; 2013 Oct; 288(40):28488-502. PubMed ID: 23955342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging roles for the FBXW7 ubiquitin ligase in leukemia and beyond.
    Kourtis N; Strikoudis A; Aifantis I
    Curr Opin Cell Biol; 2015 Dec; 37():28-34. PubMed ID: 26426760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fbxw7β resides in the endoplasmic reticulum membrane and protects cells from oxidative stress.
    Matsumoto A; Tateishi Y; Onoyama I; Okita Y; Nakayama K; Nakayama KI
    Cancer Sci; 2011 Apr; 102(4):749-55. PubMed ID: 21205095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene.
    Mao JH; Perez-Losada J; Wu D; Delrosario R; Tsunematsu R; Nakayama KI; Brown K; Bryson S; Balmain A
    Nature; 2004 Dec; 432(7018):775-9. PubMed ID: 15592418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-suppressor Fbxw7 targets SIK2 for degradation to interfere with TORC2-AKT signaling in pancreatic cancer.
    Zhang MX; Wang H; Sun GP
    Cell Biol Int; 2020 Sep; 44(9):1900-1910. PubMed ID: 32437091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct Interactions of EBP1 Isoforms with FBXW7 Elicits Different Functions in Cancer.
    Wang Y; Zhang P; Wang Y; Zhan P; Liu C; Mao JH; Wei G
    Cancer Res; 2017 Apr; 77(8):1983-1996. PubMed ID: 28209614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of miR-92a promotes the tumor growth of osteosarcoma by suppressing F-box and WD repeat-containing protein 7.
    Jiang X; Li X; Wu F; Gao H; Wang G; Zheng H; Wang H; Li J; Chen C
    Gene; 2017 Mar; 606():10-16. PubMed ID: 28069547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guttiferone K impedes cell cycle re-entry of quiescent prostate cancer cells via stabilization of FBXW7 and subsequent c-MYC degradation.
    Xi Z; Yao M; Li Y; Xie C; Holst J; Liu T; Cai S; Lao Y; Tan H; Xu HX; Dong Q
    Cell Death Dis; 2016 Jun; 7(6):e2252. PubMed ID: 27253416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of microRNA-223 regulates the ubiquitin ligase FBXW7 in oesophageal squamous cell carcinoma.
    Kurashige J; Watanabe M; Iwatsuki M; Kinoshita K; Saito S; Hiyoshi Y; Kamohara H; Baba Y; Mimori K; Baba H
    Br J Cancer; 2012 Jan; 106(1):182-8. PubMed ID: 22108521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FBXW7 acts as an independent prognostic marker and inhibits tumor growth in human osteosarcoma.
    Li Z; Xiao J; Hu K; Wang G; Li M; Zhang J; Cheng G
    Int J Mol Sci; 2015 Jan; 16(2):2294-306. PubMed ID: 25622249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fbxw7 regulates lipid metabolism and cell fate decisions in the mouse liver.
    Onoyama I; Suzuki A; Matsumoto A; Tomita K; Katagiri H; Oike Y; Nakayama K; Nakayama KI
    J Clin Invest; 2011 Jan; 121(1):342-54. PubMed ID: 21123947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opposing functions of Fbxw7 in keratinocyte growth, differentiation and skin tumorigenesis mediated through negative regulation of c-Myc and Notch.
    Ishikawa Y; Hosogane M; Okuyama R; Aoyama S; Onoyama I; Nakayama KI; Nakayama K
    Oncogene; 2013 Apr; 32(15):1921-32. PubMed ID: 22665065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.